Original news and analysis on international IP policy
Word is spreading of a recent decision by a Brazilian judge to annul a patent on a key AIDS drug, effectively allowing less expensive generic versions into the country, and calling into question other such patents.
The Free University of Brussels has set out to map predominant normative and causal beliefs regarding IP laws and policies. To give your input and participate in the survey, click on www.surveymonkey.com/s/IP_Community.
Bien que Gilead ait apporté des améliorations considérables à ses précédentes licences volontaires portant sur des médicaments antirétroviraux essentiels, les licences que l’entreprise a concédées au Medicines Patent Pool, fondation créée par UNITAID, comportent des restrictions regrettables qui fragilisent leur impact sur l’accès à des antirétroviraux génériques de qualité garantie plus abordables dans les pays en développement.
The World Intellectual Property Organization has waded into the global debates over access to safe drinking water, with an upcoming workshop on patents and water purification technologies.
Ukraine yesterday filed a World Trade Organization dispute settlement case against Australia for its 2011 law requiring plain packaging on tobacco in an effort to address the severe public health problem related to its use. The case could represent an important measure of the power of trade interests versus public health decisions by governments.
The World Health Organization is under siege by private sector forces using their financial leverage to gain undue influence in the financially beleaguered United Nations agency, a developing country-oriented group has said.
In a move welcomed by many in the international community, India has granted an application, its first, from a homegrown generic drug maker to manufacture and sell a patented cancer drug under a compulsory licence.
The controversial Anti-Counterfeiting Trade Agreement consumed hours of European Parliament time this week as the European Commission sought to persuade lawmakers to approve it. But no matter how often EC officials, academics and lawyers said the treaty will not change EU law, scepticism still remains about its potential impact on digital freedoms and access to generic medicines in developing countries – including from the Parliament member who will author the legislative report.
As the Novartis Glivec patent case in India reaches the final phase of a long-running legal battle, there’s one point on which both the Swiss pharmaceutical company and its critics agree: the significance of this case goes far beyond the protection of a single medication.
While action on the Anti-Counterfeiting Trade Agreement is occurring at the European Parliament in Brussels – including a new letter from Members of Parliament and 2.5 million petitioners in opposition - ACTA also was the subject of discussion at the World Trade Organization this week.
The World Trade Organization committee responsible for intellectual property issues today is meeting to address its usual list of topics with two recent additions of international interest. Countries negotiating the embattled Anti-Counterfeiting Trade Agreement (ACTA) and a country opposed to Australia’s public health law on tobacco packaging have added these to the agenda. Sources at the meeting say opponents of the tobacco law may be near to filing a dispute settlement case at the WTO.
High-level policymakers, industry leaders, law professors and other stakeholders came together in Geneva recently to discuss the how the role of intellectual property is evolving when it comes to developing, protecting, and providing medicines.